Great Point Partners LLC Madrigal Pharmaceuticals, Inc. Transaction History

Great Point Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $5.78 Million - $7.59 Million	95,500 New	95,500 $6.21 Million
Q1 2019 May 14, 2019	SELL	$103.48 - $143.84 $2.85 Million - $3.96 Million	-27,500 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$94.77 - $215.54 $1.22 Million - $2.78 Million	-12,900 Reduced 31.93%	27,500 $3.1 Million
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $8.37 Million - $12.1 Million	40,400 New	40,400 $8.65 Million

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.